Michael J. Farrell - 10 Nov 2022 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Executive Officer
Signature
Michael J. Farrell, Chief Executive Officer
Issuer symbol
RMD
Transactions as of
10 Nov 2022
Transactions value $
-$1,077,650
Form type
4
Filing time
14 Nov 2022, 10:56:53 UTC
Previous filing
18 Oct 2022
Next filing
15 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Gift $0 -1K -19.65% $0.00 4.09K 10 Nov 2022 Lisette and Michael Farrell Family Trust F1
transaction RMD ResMed Common Stock Gift $0 +1K +25.77% $0.00 4.88K 10 Nov 2022 Lisette and Michael Farrell Foundation F2
transaction RMD ResMed Common Stock Sale -$1.08M -4.88K -100% $220.83 0 10 Nov 2022 Lisette and Michael Farrell Foundation F3
holding RMD ResMed Common Stock 423K 10 Nov 2022 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Gift of shares transferred to The Lisette and Michael Farrell Foundation, Mr. Farrell retains dispositive power over remaining shares.
F2 Gift of shares transferred from The Lisette and Michael Farrell Family Trust, Mr. Farrell retains dispositive power over the gifted shares.
F3 This transaction was executed in multiple trades at prices ranging from $220.67 $220.97. The price reported above reflects the weighted average sale price.
F4 Includes 84.179 shares of ResMed stock purchased on October 31, 2022, through the ResMed Employee Stock Purchase Plan.